Form 6-K ONCOLYTICS BIOTECH INC For: May 15
SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16of the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number 001-38512 Oncolytics Biotech Inc. (Translation of registrant's name into English) Suite 804, 322 11th Avenue SWCalgary, Alberta, Canada T2R 0C5 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file... (continue reading...)
Form 8-K Olema Pharmaceuticals, For: May 15
false000175028400017502842024-05-152024-05-15
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2024
Olema Pharmaceuticals, Inc.
(Exact name of Registrant as Specified in Its Charter)
... (continue reading...)
Form 8-K TREVENA INC For: May 15
false
0001429560
0001429560 2024-05-15
2024-05-15 iso4217:USD
xbrli:shares
iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2024
TREVENA, INC.
(Exact name of registrant as specified in... (continue reading...)
Form 8-K Venus Concept Inc. For: May 15
false0001409269NASDAQ00014092692024-05-152024-05-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2024
... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K RADCOM LTD For: May 15
-
Form 8-K Cabaletta Bio, Inc. For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Gayer Charles K
-
Form 13F-HR MUFG Securities EMEA For: Mar 31
-
Form 6-K Flex LNG Ltd. For: May 15
-
Form 6-K COMPUGEN LTD For: May 15
-
Form 8-K Perspective Therapeutics For: May 15
-
Form 10-K Prestige Consumer Health For: Mar 31
-
Form 13F-HR Fundsmith LLP For: Mar 31
-
Form 10-Q PSQ Holdings, Inc. For: Mar 31
-
Form 8-K Predictive Oncology Inc. For: May 15
-
Form 8-K Katapult Holdings, Inc. For: May 15
-
Form 8-K DecisionPoint Systems, For: May 15
-
Form 13F-NT Quilter Cheviot Internat For: Mar 31
-
Form 10-12B/A Inhibrx Biosciences,
-
Form 10-Q Eledon Pharmaceuticals, For: Mar 31
-
Form 10-Q Sagimet Biosciences Inc. For: Mar 31
-
Form 10-Q DecisionPoint Systems, For: Mar 31
-
Form 8-K Plutonian Acquisition For: May 15
-
Form 8-K Renalytix plc For: May 15
-
Form 6-K Kenon Holdings Ltd. For: May 15
-
Form 13F-HR ABG-WTT Global Life Scie For: Mar 31
-
Form 6-K monday.com Ltd. For: May 15
-
Form 13F-HR Yu Fan For: Mar 31
-
Form 13F-HR Dragoneer Investment For: Mar 31
-
Form 13F-HR Chan Zuckerberg Initiati For: Mar 31
-
Form 13F-HR Lionstone Capital Manage For: Mar 31
-
Form 13F-NT Quilter Investors LTD For: Mar 31
-
Form 8-K CareMax, Inc. For: May 14
-
Form 13F-HR Ally Bridge Group (NY) For: Mar 31
-
Form D MA-1213 Fund I, a series
-
Form 8-K ASENSUS SURGICAL, INC. For: May 15
-
Form 6-K MAG SILVER CORP For: May 15
-
Form 10-D SANTANDER DRIVE AUTO For: Apr 30
-
Form 13F-NT Quilter Cheviot Ltd For: Mar 31
-
Form 6-K RISKIFIED LTD. For: Mar 31
-
Form 13F-HR Greytown Advisors Inc. For: Mar 31
-
Form 6-K MakeMyTrip Ltd For: May 15
-
Form 20-F Gol Intelligent Airlines For: Dec 31
-
Form ABS-EE SANTANDER DRIVE AUTO For: Apr 30
-
Form ABS-EE SANTANDER DRIVE AUTO For: Apr 30
-
Form 4 MPLX LP For: May 13 Filed by: SURMA JOHN P
-
Form FWP CRH SMW Finance DAC Filed by: CRH SMW Finance DAC
-
Form 10-D SANTANDER DRIVE AUTO For: Apr 30
-
Form 10-D SANTANDER DRIVE AUTO For: Apr 30
-
Form 10-D SANTANDER DRIVE AUTO For: Apr 30
-
Form 13F-HR SIEMENS PENSION TRUST E For: Mar 31
-
Form 10-D SANTANDER DRIVE AUTO For: Apr 30
-
Form 13F-NT Noked Capital LTD For: Mar 31
-
Form 8-K Mister Car Wash, Inc. For: May 14